| 摘要 |
<p>The present invention relates to novel bi-tryptaminic derivatives having general formula (I), wherein R1, R2, which can be similar or different, represent hydrogen or a linear or branched alkyl comprising from one to six carbon atoms, and X is a bivalent group defined in the description. It also relates to the preparation process, and to their utilization as drugs and as agonists of five-HT1-like receptors and the pharmaceutical compositions containing them.</p> |
